Alpaslan Alp

1.1k total citations
72 papers, 744 citations indexed

About

Alpaslan Alp is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Alpaslan Alp has authored 72 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 38 papers in Infectious Diseases and 10 papers in Surgery. Recurrent topics in Alpaslan Alp's work include Mycobacterium research and diagnosis (17 papers), Tuberculosis Research and Epidemiology (15 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Alpaslan Alp is often cited by papers focused on Mycobacterium research and diagnosis (17 papers), Tuberculosis Research and Epidemiology (15 papers) and SARS-CoV-2 and COVID-19 Research (11 papers). Alpaslan Alp collaborates with scholars based in Türkiye, United States and Guadeloupe. Alpaslan Alp's co-authors include Zeynep Sarıbaş, Gülşen Hasçelik, Tanıl Kocagöz, Burçin Şener, Koray Ergünay, Haluk Külah, Kübra Aykaç, Hatice Ceylan Koydemir, Canan Özgen and Ali Bülent Cengiz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Alpaslan Alp

70 papers receiving 717 citations

Peers

Alpaslan Alp

EPIDE

SURGE

ONCOL

Joanna Schaenman United States

Elena Beam United States

Lukas Weseslindtner Austria

Ali Si‐Mohamed France

Juliana Esperalba Spain

Cynthia E. Fisher United States

Karine Bolloré France

Rachel Miller United States

Ching‐Fen Shen Taiwan

Mahomed‐Yunus S. Moosa South Africa

Joanna Schaenman United States

Alpaslan Alp

287 ×0.7

305 ×0.8

EPIDE

217 ×1.3

SURGE

59 ×0.5

180 ×2.4

ONCOL

Citations per year, relative to Alpaslan Alp Alpaslan Alp (= 1×) peers Joanna Schaenman

Countries citing papers authored by Alpaslan Alp

Since Specialization

Citations

This map shows the geographic impact of Alpaslan Alp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alpaslan Alp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alpaslan Alp more than expected).

Fields of papers citing papers by Alpaslan Alp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alpaslan Alp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alpaslan Alp. The network helps show where Alpaslan Alp may publish in the future.

Co-authorship network of co-authors of Alpaslan Alp

This figure shows the co-authorship network connecting the top 25 collaborators of Alpaslan Alp. A scholar is included among the top collaborators of Alpaslan Alp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alpaslan Alp. Alpaslan Alp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Şener, Burçin, Banu Sancak, Ayşegül Gözalan, et al.. (2022). Sensitivity Affected by Disease Severity and Serum Sampling Time: a Performance Evaluation of Six SARS-CoV-2 Antibody Immunoassays. Japanese Journal of Infectious Diseases. 75(4). 388–394. 1 indexed citations

Balaban, Hatice, Abdullah Tarık Aslan, Alpaslan Alp, et al.. (2022). Hepatitis E Virus Prevalence and Associated Risk Factors in High-Risk Groups: A Cross-Sectional Study. The Turkish Journal of Gastroenterology. 33(7). 615–624. 2 indexed citations

Alp, Alpaslan. (2022). Recent Advances in Molecular Point of Care Tests. Mikrobiyoloji Bulteni. 56(3). 580–591. 5 indexed citations

Gülmez, Dolunay, Taha Koray Şahin, Burçin Halaçlı, et al.. (2022). A screening study for COVID‐19‐associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic. Mycoses. 65(7). 724–732. 17 indexed citations

Alp, Alpaslan, et al.. (2021). Respiratory Tract Pathogens in the COVID-19 Era: Data from a Pediatric Emergency Department. Journal of Pediatric Infectious Diseases. 17(1). 11–17. 1 indexed citations

Aykaç, Kübra, Yasemin Özsürekçi, Burcu Ceylan Cura Yayla, et al.. (2021). Pneumococcal carriage in children with COVID-19. Human Vaccines & Immunotherapeutics. 17(6). 1628–1634. 6 indexed citations

Aladağ, Elifcan, Meltem Gülsün Akpınar, Hakan Göker, et al.. (2021). Human Ace D/I Polymorphism Could Affect the Clinicobiological Course of COVID-19. Journal of the Renin-Angiotensin-Aldosterone System. 2021. 24 indexed citations

Balaban, Hatice, Osman Dağ, Alpaslan Alp, et al.. (2020). Retrospective Evaluation of Hepatitis C Awareness in Turkey Through Two Decades. The Turkish Journal of Gastroenterology. 32(1). 88–96. 3 indexed citations

Başaran, Nursel Çalık, Gülçin Telli Dizman, Lale Özışık, et al.. (2020). Outcome of noncritical COVID-19 patients with early hospitalization and early antiviral treatment outside the ICU. TURKISH JOURNAL OF MEDICAL SCIENCES. 51(2). 411–420. 16 indexed citations

10.

Çoban, Ahmet Yılmaz, Can Biçmen, Ali Albay, et al.. (2016). Multicenter evaluation of crystal violet decolorization assay (CVDA) for rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis. Scientific Reports. 6(1). 39050–39050. 11 indexed citations

11.

Ergünay, Koray, Cem Şimşek, Alpaslan Alp, et al.. (2013). Tedavi Naif Kronik Hepatit B Olgularında Bazal Antiviral Direncin Araştırılması. Mikrobiyoloji Bulteni. 47(4). 628–635. 3 indexed citations

12.

Balıkçı, Hasan Hüseyin, et al.. (2013). Neck masses: diagnostic analysis of 630 cases in Turkish population. European Archives of Oto-Rhino-Laryngology. 270(11). 2953–2958. 15 indexed citations

13.

Şimşek, Cem, Aslı Pinar, Akif Altınbaş, et al.. (2012). Alpha-1 antitrypsin deficiency in patients with chronic hepatitis. The Turkish Journal of Gastroenterology. 23(5). 569–573. 1 indexed citations

14.

Kısa, Özgül, Selamı Günal, Ali Albay, et al.. (2012). Distribution of Spoligotyping Defined Genotypic Lineages among Drug-Resistant Mycobacterium tuberculosis Complex Clinical Isolates in Ankara, Turkey. PLoS ONE. 7(1). e30331–e30331. 32 indexed citations

15.

Ergünay, Koray, et al.. (2011). Utility of a commercial quantitative hepatitis C virus core antigen assay in a diagnostic laboratory setting. Diagnostic Microbiology and Infectious Disease. 70(4). 486–491. 25 indexed citations

16.

Şimşek, Halis, Aslı Pinar, Akif Altınbaş, et al.. (2011). Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population. Journal of Clinical Laboratory Analysis. 25(4). 296–299. 5 indexed citations

17.

Kocagöz, Tanıl, et al.. (2011). Mycobacterial Strains That Stimulate the Immune System Most Efficiently as Candidates for the Treatment of Bladder Cancer. Microbial Physiology. 20(1). 24–28. 22 indexed citations

18.

Alp, Alpaslan & Gülşen Hasçelik. (2009). Comparison of 3 nucleic acid isolation methods for the quantification of HIV-1 RNA by Cobas Taqman real-time polymerase chain reaction system. Diagnostic Microbiology and Infectious Disease. 63(4). 365–371. 9 indexed citations

19.

Zozio, Thierry, Caroline Allix, Selamı Günal, et al.. (2005). Genotyping of Mycobacterium tuberculosis clinical isolates in two cities of Turkey: Description of a new family of genotypes that is phylogeographically specific for Asia Minor. BMC Microbiology. 5(1). 44–44. 35 indexed citations

20.

Ergan, Begüm, Lütfi Çöplü, Alpaslan Alp, & M Artvinli. (2004). Mycobacterium smegmatis pneumonia. Respirology. 9(2). 283–285. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact